Follow-up of Extreme Neonatal Hyperbilirubinemia in 5-10 Year Old Children: a Danish Population Based Study
NCT ID: NCT01599611
Last Updated: 2012-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
128 participants
OBSERVATIONAL
2010-03-31
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neonatal Hyperbilirubinaemia in the Democratic Republic of Congo
NCT03880591
Non-invasive Measurement of Hemoglobin in Infants and Neonates
NCT02655107
Transcutaneous Bilirubinometers in the Community
NCT00735319
Scintigraphic Defecography for Evaluation of Functional Outcome in an Adult Hirschsprung Population
NCT04957667
Ultrasound Measurements of Hepatic Vasculatures and Hepatic Doppler Assessment of Healthy Children
NCT04619966
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exposed group
Children age 5-10 years old who had a total serum bilirubin \> 450 umol/L in the neonatal period
Movement assessment battery for children - 2
A standardised test developed to identify developmental difficulties in children.
Non-exposed group
Matched 1:1 to the exposed group on gender, age, gestational age and municipality of residence
Movement assessment battery for children - 2
A standardised test developed to identify developmental difficulties in children.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Movement assessment battery for children - 2
A standardised test developed to identify developmental difficulties in children.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Total serum bilirubin \> 450 umol/L in the neonatal period
* Born in the period 01.01.2000 - 31.12.2005
Exclusion Criteria
5 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pernille Vandborg, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Børneafdelingen, Aalborg Sygehus, Denmark
References
Explore related publications, articles, or registry entries linked to this study.
Vandborg PK, Hansen BM, Greisen G, Mathiasen R, Kasper F, Ebbesen F. Follow-up of extreme neonatal hyperbilirubinaemia in 5- to 10-year-old children: a Danish population-based study. Dev Med Child Neurol. 2015 Apr;57(4):378-84. doi: 10.1111/dmcn.12603. Epub 2014 Oct 29.
Related Links
Access external resources that provide additional context or updates about the study.
A description of the study in Danish
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
pkv
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.